tiprankstipranks

Sanford Hillsberg Insider Profile

4 Followers
Sanford Hillsberg, Director at Iovance Biotherapeutics, holds 113.42K shares in SELLAS Life Sciences Group (Ticker: SLS), holds 154.00K shares in Iovance Biotherapeutics (Ticker: IOVA).
tipranks
Sanford Hillsberg

Sanford Hillsberg
Iovance Biotherapeutics (IOVA)
Director

Ranked #11,110 out of 98,909 Corporate Insiders

Profitable Transactions

75%
3 out of 4 Profitable Transactions

Average Return

+46.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
91.66%
8.34%
A breakdown of Sanford Hillsberg's holdings

Insider Roles

Iovance Biotherapeutics
(IOVA)
Director
SELLAS Life Sciences Group
(SLS)
Director
Roles that Sanford Hillsberg holds in companies

Most Profitable Insider Trade

Stock:
SELLAS Life Sciences Group
(SLS)
Rating:Informative Sell
Date:Jan 22, 2014 - Jan 22, 2015
Return:+72.90%
The most profitable trade made by Sanford Hillsberg

Sanford Hillsberg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Iovance Biotherapeutics
Aug 24, 2016
Director
Uninformative Sell
491.40K
$1.69M
SELLAS Life Sciences Group
Oct 10, 2017
Director
Uninformative Buy
7.98K
$153.69K
List of latest transactions for each holding click on a transaction to see Sanford Hillsberg's performance on stock

Sanford Hillsberg insider profile FAQ

What is the percentage of profitable transactions made by Sanford Hillsberg?
The percentage of profitable transactions made by Sanford Hillsberg is 75%.
    What is the average return per transaction made by Sanford Hillsberg?
    The average return per transaction made by Sanford Hillsberg is 46.60%.
      What stocks does Sanford Hillsberg hold?
      Sanford Hillsberg holds: IOVA, SLS stocks.
        What was Sanford Hillsberg’s latest transaction?
        Sanford Hillsberg latest transaction was an Uninformative Buy of $7.98K.
          What was Sanford Hillsberg's most profitable transaction?
          Sanford Hillsberg’s most profitable transaction was an Informative Sell of SLS stock on January 22, 2014. The return on the trade was 72.90%.
            What is Sanford Hillsberg's role in Iovance Biotherapeutics?
            Sanford Hillsberg's role in Iovance Biotherapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.